Iron sucrose accelerates early atherogenesis by increasing superoxide production and upregulating adhesion molecules in CKD

Journal of the American Society of Nephrology

Volumn 25, Issue 11, 2014, Pages 2596-2606

  Kuo, Ko Lin ^a,b   Hung, Szu Chun ^b   Lee, Tzong Shyuan ^a,c   Tarng, Der Cherng ^a,d  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI TZU CHI HOSPITAL   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

^d TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; CELL ADHESION MOLECULE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; IRON SACCHARATE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE; VASCULAR CELL ADHESION MOLECULE 1; FERRIC ION; FERRIC OXIDE, SACCHARATED; ICAM1 PROTEIN, MOUSE; SACCHARIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CELL INTERACTION; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DISEASE EXACERBATION; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; LEUKOCYTE; LIPID PEROXIDATION; MONONUCLEAR CELL; MOUSE; NEPHRECTOMY; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; C57BL MOUSE; CELL ADHESION; CHEMICALLY INDUCED; CHRONIC KIDNEY FAILURE; CYTOLOGY; DRUG EFFECTS; INTRAVENOUS DRUG ADMINISTRATION; MALE; METABOLISM; MONOCYTE; PATHOLOGY; PHYSIOLOGY; U937 CELL LINE;

ANIMALS; ATHEROSCLEROSIS; CELL ADHESION; ENDOTHELIAL CELLS; FERRIC COMPOUNDS; GLUCARIC ACID; HUMANS; INJECTIONS, INTRAVENOUS; INTERCELLULAR ADHESION MOLECULE-1; LEUKOCYTES; LIPID PEROXIDATION; MALE; MICE, INBRED C57BL; MONOCYTES; NF-KAPPA B; RENAL INSUFFICIENCY, CHRONIC; SUPEROXIDES; U937 CELLS; UP-REGULATION; VASCULAR CELL ADHESION MOLECULE-1;

EID: 84923950749     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2013080838     Document Type: Article

References (48)

1. Parfrey PS, Foley RN, Wittreich BH, Sullivan DJ, Zagari MJ, Frei D: Double-blind comparison of full and partial anemia correction in incident hemodialysis patients without symptomatic heart disease. J Am Soc Nephrol 16: 2180-2189, 2005
2. Hörl WH: Clinical aspects of iron use in the anemia of kidney disease. J Am Soc Nephrol 18: 382-393, 2007
3. Besarab A, Amin N, Ahsan M, Vogel SE, Zazuwa G, Frinak S, Zazra JJ, Anandan JV, Gupta A: Optimization of epoetin therapy with intravenous iron therapy in hemodialysis patients. J Am Soc Nephrol 11: 530-538, 2000
4. Rooyakkers TM, Stroes ES, Kooistra MP, van Faassen EE, Hider RC, Rabelink TJ, Marx JJ: Ferric saccharate induces oxygen radical stress and endothelial dysfunction in vivo. Eur J Clin Invest 32[Suppl 1]: 9-16, 2002
5. Drüeke T, Witko-Sarsat V, Massy Z, Descamps-Latscha B, Guerin AP, Marchais SJ, Gausson V, London GM: Iron therapy, advanced oxidation protein products, and carotid artery intima-media thickness in end-stage renal disease. Circulation 106: 2212-2217, 2002
6. Kuo KL, Hung SC, Lin YP, Tang CF, Lee TS, Lin CP, Tarng DC: Intravenous ferric chloride hexahydrate supplementation induced endothelial dysfunction and increased cardiovascular risk among hemodialysis patients. PLoS ONE 7: e50295, 2012
7. Kalantar-Zadeh K, Regidor DL, McAllister CJ, Michael B, Warnock DG: Time-dependent associations between iron and mortality in hemodialysis patients. J Am Soc Nephrol 16: 3070-3080, 2005
8. Pang JH, Jiang MJ, Chen YL, Wang FW, Wang DL, Chu SH, Chau LY: Increased ferritin gene expression in atherosclerotic lesions. J Clin Invest 97: 2204-2212, 1996
9. Lee TS, Shiao MS, Pan CC, Chau LY: Iron-deficient diet reduces atherosclerotic lesions in apoE-deficient mice. Circulation 99: 1222-1229, 1999
10. Kirk EA, Heinecke JW, LeBoeuf RC: Iron overload diminishes atherosclerosis in apoE-deficient mice. J Clin Invest 107: 1545-1553, 2001
11. Lim CS, Vaziri ND: The effects of iron dextran on the oxidative stress in cardiovascular tissues of rats with chronic renal failure. Kidney Int 65: 1802-1809, 2004
12. Griendling KK, Sorescu D, Lassègue B, Ushio-Fukai M: Modulation of protein kinase activity and gene expression by reactive oxygen species and their role in vascular physiology and pathophysiology. Arterioscler Thromb Vasc Biol 20: 2175-2183, 2000
13. Kuo KL, Hung SC, Wei YH, Tarng DC: Intravenous iron exacerbates oxidative DNA damage in peripheral blood lymphocytes in chronic hemodialysis patients. J Am Soc Nephrol 19: 1817-1826, 2008
14. Zager RA, Johnson AC, Hanson SY: Parenteral iron nephrotoxicity: Potential mechanisms and consequences. Kidney Int 66: 144-156, 2004
15. Chien CT, Lee PH, Chen CF, Ma MC, Lai MK, Hsu SM: De novo demonstration and co-localization of free-radical production and apoptosis formation in rat kidney subjected to ischemia/reperfusion. J Am Soc Nephrol 12: 973-982, 2001
16. Henle ES, Luo Y, Gassmann W, Linn S: Oxidative damage to DNA constituents by iron-mediated fenton reactions. The deoxyguanosine family. J Biol Chem 271: 21177-21186, 1996
17. Sullivan JL: Iron and the sex difference in heart disease risk. Lancet 1: 1293-1294, 1981
18. Salonen JT, Nyyssönen K, Korpela H, Tuomilehto J, Seppänen R, Salonen R: High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men. Circulation 86: 803-811, 1992
19. Kiechl S, Willeit J, Egger G, Poewe W, Oberhollenzer F: Body iron stores and the risk of carotid atherosclerosis: Prospective results from the Bruneck study. Circulation 96: 3300-3307, 1997
20. Evans PJ, Smith C, Mitchinson MJ, Halliwell B: Metal ion release from mechanically-disrupted human arterial wall. Implications for the development of atherosclerosis. Free Radic Res 23: 465-469, 1995
21. Stadler N, Lindner RA, Davies MJ: Direct detection and quantification of transition metal ions in human atherosclerotic plaques: Evidence for the presence of elevated levels of iron and copper. Arterioscler Thromb Vasc Biol 24: 949-954, 2004
22. Feldman HI, Santanna J, Guo W, Furst H, Franklin E, Joffe M, Marcus S, Faich G: Iron administration and clinical outcomes in hemodialysis patients. J Am Soc Nephrol 13: 734-744, 2002
23. Feldman HI, Joffe M, Robinson B, Knauss J, Cizman B, Guo W, Franklin-Becker E, Faich G: Administration of parenteral iron and mortality among hemodialysis patients. J Am Soc Nephrol 15: 1623-1632, 2004
24. Zager RA, Johnson AC, Hanson SY, Wasse H: Parenteral iron formulations: A comparative toxicologic analysis and mechanisms of cell injury. Am J Kidney Dis 40: 90-103, 2002
25. Carlini RG, Alonzo E, Bellorin-Font E, Weisinger JR: Apoptotic stress pathway activation mediated by iron on endothelial cells in vitro. Nephrol Dial Transplant 21: 3055-3061, 2006
26. Kamanna VS, Ganji SH, Shelkovnikov S, Norris K, Vaziri ND: Iron sucrose promotes endothelial injury and dysfunction and monocyte adhesion/infiltration. Am J Nephrol 35: 114-119, 2012
27. Chen YH, Lin SJ, Chen JW, Ku HH, Chen YL: Magnolol attenuates VCAM-1 expression in vitro in TNF-alpha-treated human aortic endothelial cells and in vivo in the aorta of cholesterol-fed rabbits. Br J Pharmacol 135: 37-47, 2002
28. Ito S, Osaka M, Higuchi Y, Nishijima F, Ishii H, Yoshida M: Indoxyl sulfate induces leukocyte-endothelial interactions through up-regulation of E-selectin. J Biol Chem 285: 38869-38875, 2010
29. Chen JW, Lin FY, Chen YH, Wu TC, Chen YL, Lin SJ: Carvedilol inhibits tumor necrosis factor-alpha-induced endothelial transcription factor activation, adhesion molecule expression, and adhesiveness to human mononuclear cells. Arterioscler Thromb Vasc Biol 24: 2075-2081, 2004
30. Li L, Frei B: Prolonged exposure to LPS increases iron, heme, and p22phox levels and NADPH oxidase activity inhuman aortic endothelial cells: Inhibition by desferrioxamine. Arterioscler Thromb Vasc Biol 29: 732-738, 2009
31. DiDonato JA, Hayakawa M, Rothwarf DM, Zandi E, Karin M: A cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB. Nature 388: 548-554, 1997
32. Kim SR, Bae YH, Bae SK, Choi KS, Yoon KH, Koo TH, Jang HO, Yun I, Kim KW, Kwon YG, Yoo MA, Bae MK: Visfatin enhances ICAM-1 and VCAM-1 expression through ROS-dependent NF-kappaB activation in endothelial cells. Biochim Biophys Acta 1783: 886-895, 2008
33. Zhang SH, Reddick RL, Piedrahita JA, Maeda N: Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science 258: 468-471, 1992
34. Buzello M, Törnig J, Faulhaber J, Ehmke H, Ritz E, Amann K: The apolipoprotein e knockout mouse: A model documenting accelerated atherogenesis in uremia. J Am Soc Nephrol 14: 311-316, 2003
35. Bro S, Bentzon JF, Falk E, Andersen CB, Olgaard K, Nielsen LB: Chronic renal failure accelerates atherogenesis in apolipoprotein E-deficient mice. J Am Soc Nephrol 14: 2466-2474, 2003
36. Bro S, Moeller F, Andersen CB, Olgaard K, Nielsen LB: Increased expression of adhesion molecules in uremic atherosclerosis in apolipo-protein-E-deficient mice. J Am Soc Nephrol 15: 1495-1503, 2004
37. Massy ZA, Ivanovski O, Nguyen-Khoa T, Angulo J, Szumilak D, Mothu N, Phan O, Daudon M, Lacour B, Drüeke TB, Muntzel MS: Uremia accelerates both atherosclerosis and arterial calcification in apolipoprotein E knockout mice. J Am Soc Nephrol 16: 109-116, 2005
38. Griendling KK, Harrison DG: Out, damned dot: Studies of the NADPH oxidase in atherosclerosis. J Clin Invest 108: 1423-1424, 2001
39. Kurtoglu E, Ugur A, Baltaci AK, Mogolkoc R, Undar L: Activity of neutrophil NADPH oxidase in iron-deficient anemia. Biol Trace Elem Res 96: 109-115, 2003
40. Ridker PM, Hennekens CH, Roitman-Johnson B, Stampfer MJ, Allen J: Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men. Lancet 351: 88-92, 1998
41. Hwang SJ, Ballantyne CM, Sharrett AR, Smith LC, Davis CE, Gotto AM Jr, Boerwinkle E: Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: The Atherosclerosis Risk In Communities (ARIC) study. Circulation 96: 4219-4225, 1997
42. Stenvinkel P, Wanner C, Metzger T, Heimbürger O, Mallamaci F, Tripepi G, Malatino L, Zoccali C: Inflammation and outcome in endstage renal failure: Does female gender constitute a survival advantage? Kidney Int 62: 1791-1798, 2002
43. Papayianni A, Alexopoulos E, Giamalis P, Gionanlis L, Belechri AM, Koukoudis P, Memmos D: Circulating levels of ICAM-1, VCAM-1, and MCP-1 are increased in haemodialysis patients: Association with inflammation, dyslipidaemia, and vascular events. Nephrol Dial Transplant 17: 435-441, 2002
44. Stenvinkel P, Lindholm B, Heimbürger M, Heimbürger O: Elevated serum levels of soluble adhesion molecules predict death in predialysis patients: Association with malnutrition, inflammation, and cardiovascular disease. Nephrol Dial Transplant 15: 1624-1630, 2000
45. Papagianni A, Dovas S, Bantis C, Belechri AM, Kalovoulos M, Dimitriadis C, Efstratiadis G, Alexopoulos E, Memmos D: Carotid atherosclerosis and endothelial cell adhesionmolecules as predictors of long-termoutcomein chronic hemodialysis patients. Am J Nephrol 28: 265-274, 2008
46. Wang AY, Lam CW, Wang M, Woo J, Chan IH, Lui SF, Sanderson JE, Li PK: Circulating soluble vascular cell adhesionmolecule 1: Relationships with residual renal function, cardiac hypertrophy, and outcome of peritoneal dialysis patients. Am J Kidney Dis 45: 715-729, 2005
47. Yin WH, Chen JW, Young MS, Lin SJ: Increased endothelial monocyte adhesiveness is related to clinical outcomes in chronic heart failure. Int J Cardiol 121: 276-283, 2007
48. Vu'o'ng Lê B, Khorsi-Cauet H, Villegier AS, Bach V, Gay-Quéheillard J: New rat models of iron sucrose-induced iron overload. Exp Biol Med (Maywood) 236: 790-799, 2011